Michael Schmertzler Ptc Therapeutics, Inc. (PTCT) insider trading activity

Michael Schmertzler is of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 155,266 shares of PTCT, which is worth approximately $11.7 Million. The most recent transaction as insider was on Dec 16, 2025, when has been sold 24,000 shares (Common Stock) at a price of $30.86 per share, resulting in proceeds of $740,640. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 155K

18.28% 3M change

25.96% 12M change

Total Value Held $11.7 Million

MICHAEL SCHMERTZLER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 16 2025	BUY Exercise of conversion of derivative security	$740,640 $30.86 p/Share	24,000 Added 13.39%	155,266 Common Stock
Jan 03 2025	BUY Grant, award, or other acquisition	-	8,000 Added 5.74%	131,266 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	-	8,000 Added 6.09%	123,266 Common Stock
Jan 08 2024	SELL Open market or private sale	$41,715 $27.81 p/Share	1,500 Reduced 1.28%	115,266 Common Stock
Jun 07 2023	SELL Open market or private sale	$44,860 $44.86 p/Share	1,000 Reduced 0.85%	116,766 Common Stock
Jan 05 2023	BUY Grant, award, or other acquisition	-	8,000 Added 6.36%	117,766 Common Stock
Jan 07 2022	BUY Grant, award, or other acquisition	-	6,400 Added 5.51%	109,766 Common Stock

Jan 06 2021	BUY Grant, award, or other acquisition	-	3,300 Added 3.09%	103,366 Common Stock

Also insider at

HLNE

Hamilton Lane INC Financial Services

> 10% Shareholder